产品名称
MISSION® esiRNA, targeting human PARP16
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ATCTGCTGCTGCTGCTCATAGTGAGTGTCATCAACTCCTCTGCTTTCCAACACTTTTGGAATCGTGCGAAAAGATAATCTTTCTGGGCCTGGTGTGGGGGCTACCTCAACTATGTGCCTTATGGTAACTTGTTCTGTACCTCCTATGCCTCATGTCCAGCCAGGTTGAGCCTAGGGGCCAGTTGGGGGACCACAGGACAATTTTCATATGGCCTAAATGTATCCATTGCCTTTGATGATGTTCCCAGCCATACTCCAGTCAACGGGGACTACTAGTCCCTCACTCTTAGGTTTTAGGGGAGTCCTTCCATCTGCTCCTTCTTAAACTGTCCTAGGGAGTTGGCTTTTCAGCCAGGGCCAAAGGAAAAAGCCCTGCTGCATTTAAAAACAAAGTGTCCAAGCTGTCAGTGGTGTGT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... PARP16(54956), PARP16(54956)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Haritha Kunhiraman et al.
Molecular and cellular biochemistry, 471(1-2), 15-27 (2020-05-31)
The biological activity of vascular endothelial growth factor (VEGF), the major cytokine regulating the process of angiogenesis is tightly controlled at multiple levels including processes involving post-translational modification such as ADP-ribosylation and glycosylation. ADP-ribosylation is a reversible NAD+-dependent modification, catalyzed
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持